AstraZenenca liver cancer combination treatment approved by FDA
24th Oct 2022 07:19
(Sharecast News) - AstraZeneca said its Imjudo drug, in combination with Imfinzi, hadbeen approved in the US for the treatment of adult patients with unresectable hepatocellular carcinoma (HCC), the most common type of liver cancer, the company said on Monday.
Read moreJapan green lights AstraZeneca asthma drug
27th Sep 2022 08:28
(Sharecast News) - AstraZeneca drug Tezspire has been approved for use with patients with severe asthma in Japan, the blue chip confirmed on Tuesday.
Read moreAstraZeneca's gMG treatment receives EU approval
23rd Sep 2022 07:27
(Sharecast News) - Drugmaker AstraZeneca said on Friday that Ultomiris, its long-acting C5 inhibitor, had received EU approval to be used in the treatment of adult patients with generalised myasthenia gravis, a rare autoimmune neuromuscular disease.
Read moreAstraZeneca's severe asthma treatment gets EU approval
21st Sep 2022 07:05
(Sharecast News) - Drugmaker AstraZeneca said on Wednesday that Tezspire, its severe asthma treatment, had received EU approval for use as an add-on maintenance treatment in patients 12 years and older.
Read moreAstraZeneca's Covid-19 antibody combination receives EU approval
20th Sep 2022 07:46
(Sharecast News) - Drugmaker AstraZeneca said on Tuesday that Evusheld, its long-acting antibody combination, had been granted approval for the treatment of adults and adolescents with Covid-19 in the European Union.
Read moreAstraZeneca blod clot treatment meets trial endpoint
16th Sep 2022 07:28
(Sharecast News) - AstraZeneca on Friday said its Danicopan add-on anti blood-clotting drug had met a primary endpoint in a phase III trial.
Read moreAstraZeneca, Sanofi respiratory drug gets EU marketing go-ahead
16th Sep 2022 07:02
(Sharecast News) - AstraZeneca and Sanofi said their Beyfortus drug for the prevention of lower respiratory tract disease in newborns and infants has been recommended for marketing authorisation in the European Union
Read moreCredit Suisse upgrades GSK, downgrades AstraZeneca
15th Sep 2022 13:49
(Sharecast News) - Credit Suisse upgraded GlaxoSmithKline on Thursday but downgraded AstraZeneca as it took a look at the pharmaceuticals sector.
Read moreAstraZeneca's biliary tract cancer treatment receives US approval
5th Sep 2022 07:08
(Sharecast News) - Drugmaker AstraZeneca said on Monday that its biliary tract cancer treatment had been granted US approval to be used as the first immunotherapy regimen for patients with the disease.
Read moreAstraZeneca's Evusheld approved in Japan for treatment, prevention of Covid-19
30th Aug 2022 13:42
(Sharecast News) - AstraZeneca said on Tuesday that its Evusheld long-acting antibody combination has been approved in Japan for the prevention and treatment of Covid-19.
Read moreClinical trials demonstrate that AstraZeneca's Farxiga reduces risk of cardiovascular death
30th Aug 2022 07:20
(Sharecast News) - Clinical trial results showed that AstraZeneca's Farxiga treatment against Type II diabetes significantly reduced the risk of cardiovascular death or worsening of heart failure in patients with mildly reduced or preserved ejection fraction.
Read moreShoreCap stays at 'buy' for Astra Zeneca, citing prospects for earnings and sales growth, pipeline
25th Aug 2022 15:43
(Sharecast News) - Analysts at ShoreCap doubled down on their recent reinitiation of coverage on AstraZeneca with a 'buy' recommendation, citing growth and pipeline prospects.
Read moreAstraZeneca's Lynparza approved in Japan
25th Aug 2022 08:05
(Sharecast News) - AstraZeneca and MSD's Lynparza has been approved in Japan for the treatment of patients with BRCA-mutated (BRCAm), HER2-negative early breast cancer at high risk of recurrence, the companies said on Thursday.
Read moreSector movers: Defensives knocking at technical resistance's door
20th Aug 2022 17:01
(Sharecast News) - Interest rate sensitive segments of the FTSE 3500 dragged the index lower at the end of the week, as investors digested a flurry of Fed speakers overnight whose overarching message appeared to be that interest rates would remain higher for longer, although there were slight variations as to just how high.
Read moreAstraZeneca's prostate cancer drug gets US priority review
16th Aug 2022 08:07
(Sharecast News) - Pharmaceutical company AstraZeneca said its Lynparza prostate cancer treatment application had been granted priority review in the US.
Read more